GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » EV-to-FCF

Parnax Lab (BOM:506128) EV-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Parnax Lab's Enterprise Value is ₹1,866 Mil. Parnax Lab's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil. Therefore, Parnax Lab's EV-to-FCF for today is .

The historical rank and industry rank for Parnax Lab's EV-to-FCF or its related term are showing as below:

BOM:506128' s EV-to-FCF Range Over the Past 10 Years
Min: -937.55   Med: 0   Max: 62.12
Current: -11.24

During the past 13 years, the highest EV-to-FCF of Parnax Lab was 62.12. The lowest was -937.55. And the median was 0.00.

BOM:506128's EV-to-FCF is ranked worse than
100% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23 vs BOM:506128: -11.24

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), Parnax Lab's stock price is ₹93.93. Parnax Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹8.380. Therefore, Parnax Lab's PE Ratio for today is 11.21.


Parnax Lab EV-to-FCF Historical Data

The historical data trend for Parnax Lab's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab EV-to-FCF Chart

Parnax Lab Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.80 -326.04 -25.15 11.77 -13.70

Parnax Lab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.77 - - - -13.70

Competitive Comparison of Parnax Lab's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Parnax Lab's EV-to-FCF falls into.



Parnax Lab EV-to-FCF Calculation

Parnax Lab's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1866.461/0
=

Parnax Lab's current Enterprise Value is ₹1,866 Mil.
Parnax Lab's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab  (BOM:506128) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Parnax Lab's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=93.93/8.380
=11.21

Parnax Lab's share price for today is ₹93.93.
Parnax Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.380.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Parnax Lab EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Parnax Lab's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab (BOM:506128) Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines